MADRID (360Dx) – Becton Dickinson over the weekend provided a roadmap for its molecular diagnostics and microbiology laboratory businesses with the unveiling of several soon-to-be launched products.

At the European Congress of Clinical Microbiology and Infectious Diseases held here, BD introduced its first new molecular testing platform in several years, the BD Cor, a fully automated high-throughput, real-time PCR testing system expected to launch next year in Europe and compete with the likes of similar platforms offered by Roche, Abbott, and Hologic.